Correlation of SARS-CoV-2-breakthrough infections to time-from-vaccine

The short-term effectiveness of a two-dose regimen of the BioNTech/Pfizer mRNA BNT162b2 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine was widely demonstrated. However, long term effectiveness is still unknown. Leveraging the centralized computerized database of Maccabi Healthc...

Descripción completa

Detalles Bibliográficos
Autores principales: Mizrahi, Barak, Lotan, Roni, Kalkstein, Nir, Peretz, Asaf, Perez, Galit, Ben-Tov, Amir, Chodick, Gabriel, Gazit, Sivan, Patalon, Tal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569006/
https://www.ncbi.nlm.nih.gov/pubmed/34737312
http://dx.doi.org/10.1038/s41467-021-26672-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569006/
https://www.ncbi.nlm.nih.gov/pubmed/34737312
http://dx.doi.org/10.1038/s41467-021-26672-3

Ejemplares similares